Peer-influenced content. Sources you trust. No registration required. This is HCN.


Journal of Clinical Oncology

Prospective Cardiovascular Surveillance of Immune Checkpoint Inhibitor–Based Combination Therapy in Patients with Advanced RCC: Data from the Phase III JAVELIN Renal 101 Trial

Cardiology March 15th 2022

JAMA Network

Assessment of Capecitabine and Bevacizumab with or Without Atezolizumab for the Treatment of Refractory Metastatic Colorectal Cancer: A Randomized Clinical Trial

Oncology, Medical February 23rd 2022

Journal of Clinical Oncology

Phase II Study of Copanlisib in Patients with Tumors with PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F

Oncology, Medical February 15th 2022

JAMA Network

Uptake and Survival Outcomes Following Immune Checkpoint Inhibitor Therapy

Hematology November 9th 2021

Dana-Farber Cancer Institute

Antibiotic Novobiocin Found to Kill Tumor Cells with DNA-Repair Glitch

Family Medicine/General Practice July 26th 2021

JAMA Network

Association Between First-Line Immune Checkpoint Inhibition and Survival for Medicare-Insured Patients With Advanced Non–Small Cell Lung Cancer

Geriatrics June 2nd 2021